Press "Enter" to skip to content

New patent expiration for Takeda Pharms drug ULORIC

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Takeda Pharms drug ULORIC

Annual Drug Patent Expirations for ULORIC
Annual Drug Patent Expirations for ULORIC

Uloric is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from four suppliers. There are five patents protecting this drug and one Paragraph IV challenge.

ULORIC drug price trends.

Drug patent litigation for ULORIC.

This drug has ninety-five patent family members in thirty-five countries.

The generic ingredient in ULORIC is febuxostat. Four suppliers are listed for this compound. Additional details are available on the febuxostat profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Takeda Pharms drug ULORIC
    Do NOT follow this link or you will be banned from the site!